Medical skin mountable device

US9592336B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9592336-B2
Application numberUS-201113026691-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2011
Priority dateOct 27, 2003
Publication dateMar 14, 2017
Grant dateMar 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device is provided comprising a transcutaneous device unit and a reservoir unit. The transcutaneous device unit comprises a transcutaneous device for transporting a fluid through a skin portion of a subject, and a mounting surface adapted for application to the skin of the subject. The reservoir unit comprises a reservoir adapted to contain a fluid drug, the reservoir comprising an outlet means allowing the transcutaneous device to be arranged in fluid communication with an interior of the reservoir, and an expelling assembly for expelling a fluid drug out of the reservoir and through the skin of the subject via the transcutaneous device. The transcutaneous device unit and the reservoir unit further comprise coupling means allowing the reservoir unit to be secured to the transcutaneous device unit in the situation of use. By this arrangement a two-unit system is provided which can be used in a convenient and cost-effective manner.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical device, comprising a first unit and a second unit configured to be secured to each other in a situation of use, the first unit being in the form of a transcutaneous device unit comprising: a transcutaneous device having a mounting surface comprising an adhesive allowing the mounting surface to be attached to a skin surface of a subject, the second unit being in the form of a removable and re-usable reservoir unit comprising: a unitary housing enclosing a reservoir configured to contain a fluid drug and an expelling assembly, and the expelling assembly being configured to cooperate with the reservoir to expel fluid drug out of the reservoir and through the skin of the subject via the transcutaneous device, the expelling assembly comprising a mechanical pump in combination with an electronically controlled actuator, an electrical energy source and a processor configured to control the mechanical pump, the removable and re-usable reservoir unit being without an adhesive for mounting to the skin surface of the subject. 2. A medical device as in claim 1 , wherein the first unit and second unit are disposable and have a first and second operation life respectively, the second operational life being longer than the first operational life. 3. A medical device as in claim 1 , wherein fluid communication between the transcutaneous device and the reservoir is established when the transcutaneous device unit and the reservoir unit are secured to each other. 4. A medical device as in claim 1 , wherein the expelling assembly is configured to be activated when the transcutaneous device unit and the reservoir unit are secured to each other and de-activated when the units are released from each other. 5. A medical device as in claim 1 , wherein the pump has an inlet configured for fluid communication with the reservoir, and an outlet configured for fluid communication with the transcutaneous device, allowing the transcutaneous device to be in fluid communication with the interior of the reservoir. 6. A medical device as in claim 5 , wherein the pump comprises an internal flow path arranged between the inlet and the outlet, the inlet and the outlet sealing the interior of the pump and thereby the flow path in an initial sterile state. 7. A medical device as in claim 6 , wherein the reservoir unit is transformable from an initial condition in which there is no fluid communication between the pump and the reservoir to a non-reversible operating condition in which fluid communication is established between the inlet of the pump and the reservoir when the pump unit is secured to the transcutaneous device unit for the first time. 8. A medical device as in claim 7 , wherein a fluid connector is configured within the interior of the pump in the initial condition, the fluid connector comprising an inlet and an outlet, wherein the fluid connector is configured to be operated from the initial condition and to an operating condition in which fluid communication is established between the interior of the reservoir and the interior of the pump via the fluid connector and with the outlet of the fluid connector being arranged in the flow path of the pump. 9. A medical device as in claim 8 , wherein the outlet of the fluid connector comprises a pointed inlet end, the reservoir comprising a penetrable portion configured for penetration by the pointed inlet end. 10. A medical device as in claim 1 , wherein the transcutaneous device comprises a pointed end configured to penetrate the skin of a subject, the pointed end being moveable between an initial position in which the pointed end is retracted relative to the mounting surface, and an extended position in which the pointed end projects relative to the mounting surface. 11. A medical device as in claim 10 , wherein the transcutaneous device unit comprises a transcutaneous device actuator configured to move the pointed end of the transcutaneous device between the initial and the extended positions. 12. A medical device as in claim 10 , wherein the transcutaneous device unit comprises a blocking device configured to block the transcutaneous device actuator, the blocking device being released when the transcutaneous device unit and the reservoir unit are secured to each other, allowing the transcutaneous device actuator to be actuated. 13. A medical device as in claim 12 , wherein the expelling assembly is activated when the electronically controlled actuator is actuated. 14. A medical device as in claim 10 , wherein the pointed end of the transcutaneous device is moveable between the extended position in which the pointed end projects relative to the mounting surface, and a retracted position in which the pointed end is retracted relative to the mounting surface. 15. A medical device as in claim 14 , further comprising a retraction device configured to move the pointed end of the transcutaneous device between the extended and the retracted position when the retraction device is actuated. 16. A medical device as in claim 15 , wherein the expelling assembly is deactivated when the retraction device is actuated. 17. A medical device as in claim 1 , wherein the transcutaneous device comprises a first portion having a pointed end and a second portion having a second end, the second portion being in fluid communication with the first portion. 18. A medical device as in claim 17 , wherein the second end comprises a pointed needle end, the pump having an outlet comprising a needle-penetrable septum allowing a fluid communication to be established between the second end of the transcutaneous device and the pump. 19. A medical device as in claim 1 , further comprising a releasable mating coupling for securing the transcutaneous device unit and the reservoir unit to each other. 20. A medical device as in claim 19 , wherein the expelling assembly is deactivated when the two units are released from each other. 21. A medical device as in claim 1 , wherein the reservoir is prefilled with a liquid drug. 22. A medical device as in claim 1 , wherein the reservoir, in a situation of use, comprises a liquid drug but substantially no enclosed free gas. 23. A medical device as in claim 1 , in combination with a plurality of removable and re-usable reservoir units, the transcutaneous device unit and the plurality of removable and re-usable reservoir units forming a system, wherein each of the plurality of removable and re-usable reservoir unit has different capabilities, wherein the transcutaneous device unit and the plurality of removable and re-usable reservoir units each comprise a mating coupling allowing each of the plurality of removable and re-usable reservoir unit to be secured to the transcutaneous device unit to provide fluid communication between each of the respective reservoirs and the transcutaneous device, and wherein each combination of the transcutaneous device unit and one of the plurality of removable and re-usable reservoir unit provides an assembly having different capabilities. 24. A medical device as in claim 23 , wherein a first reservoir unit of the plurality of removable and re-usable reservoirs comprises a first amount of a drug and a second reservoir unit of the plurality of removable and re-usable reservoirs comprises a second amount of the drug. 25. A medical device as in claim 23 , wherein a first reservoir unit of the plurality of removable and re-usable reservoirs com

Assignees

Inventors

Classifications

  • the bags being substantially completely surrounded by fluid · CPC title

  • Reciprocating piston type · CPC title

  • of the skin patch type · CPC title

  • Needle inserters · CPC title

  • the piston being actuated by fluid pressure · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9592336B2 cover?
A medical device is provided comprising a transcutaneous device unit and a reservoir unit. The transcutaneous device unit comprises a transcutaneous device for transporting a fluid through a skin portion of a subject, and a mounting surface adapted for application to the skin of the subject. The reservoir unit comprises a reservoir adapted to contain a fluid drug, the reservoir comprising an ou…
Who is the assignee on this patent?
Nielsen Ole Christian, Radmer Jim, Preuthun Jan Harald, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61M5/14248. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).